Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, and markets medical device products and systems for use in respiratory and acute care, and the treatment of obstructive sleep apnea (OSA). The company offers a range of continuous positive airway pressure (CPAP) devices, masks, and humidifiers, which comprise nasal, full face, direct nasal, and oral masks. It also provides heated humidification systems for use during the treatment of respiratory conditions, including invasive ventilation, noninvasive ventilation, nasal high flow, face mask oxygen, low flow oxygen, and humidity therapy solutions for adults and pediatric care; and T-piece resuscitation, invasive ventilation, CPAP therapy, nasal high flow, and low flow therapy solutions for infants. In addition, the company offers humidification systems for use in surgical procedures to prevent unnecessary cellular damage by protecting tissue against the harmful effects of cold, dry carbon dioxide2. Fisher & Paykel Healthcare Corporation Limited sells its products through its distribution subsidiaries, third party distributors, and original equipment manufacturers in North America, Europe, the Asia-Pacific, and New Zealand. The company was founded in 1934 and is headquartered in Auckland, New Zealand.

Key Statistics